Pirson Y, Polla-Imhoof B, Vandenbroucke J M, Lafontaine J J, Squifflet J P, Cosyns J P, Alexandre G P, van Ypersele de Strihou C
Proc Eur Dial Transplant Assoc. 1983;19:208-14.
We have reviewed 27 diabetic patients treated between 1971 and 1981 by haemodialysis and/or by transplantation. Overall patient survival is 43 per cent at five years (vs 78 per cent in non-diabetics of similar age). Two year patient survival is identical (73%) with haemodialysis and after transplantation. One year graft survival is 55 per cent. Progression of extrarenal diabetic complications is similar in haemodialysis and after transplantation. Recurrence of diabetic glomerulosclerosis was documented in two grafts. Haemodialysis thus offers a suitable alternative for diabetic patients who cannot be transplanted.
我们回顾了1971年至1981年间接受血液透析和/或移植治疗的27例糖尿病患者。总体患者五年生存率为43%（同龄非糖尿病患者为78%）。血液透析和移植后的两年患者生存率相同（73%）。一年移植肾生存率为55%。血液透析和移植后肾外糖尿病并发症的进展相似。在两个移植肾中记录到糖尿病肾小球硬化复发。因此，血液透析为无法进行移植的糖尿病患者提供了一种合适的替代方案。
